drugset / Trial / NCT06908642
Evaluation the Safety of hemay005 Tablets
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Explore the influence of different administration methods (titration/non-titration) of Hemay005 tablets on the incidence of adverse reactions.
Timeline
- Start
- 2024-12-25
- Primary completion
- 2025-06-03
- Completion
- 2025-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MUFEMILAST | Small molecule | 45 mg | — |
| Comparator | MUFEMILAST | Small molecule | 60 mg | — |
| Comparator | MUFEMILAST | Small molecule | 75 mg | — |